Urine Test Works for HPV Screening
Urine tests effectively screen for HPV, but more data is needed to determine whether they can correctly diagnose cervical disease.
Should the Exit Age for Cervical Cancer Screening Be Extended?
The highest rates of cervical cancer occur in women aged 65 to 69, according to new estimates. This suggests that screening guidelines may need to be reconsidered.
Vaccine Treatments Trigger Cervical Lesions to Disappear
New research, led by Connie Trimble, MD, shows that vaccine treatments for women with high-grade cervical dysplasia can trigger an immune response that may induce some lesions to resolve.
Study Calls into Question Appropriate Age to Stop Cervical Cancer Screening
New evidence reveals that there may be a benefit to continuing cervical cancer screening beyond age 65 years.
New Evidence Shows Benefit to Screening Older Women for Cervical Cancer
Women whose cervical cancer screening ceased between ages 50 and 64 years were 6 times more likely than women who were screened to have cervical cancer from ages 65 to 83 years.
Women With CIN3 Need Continued Follow-Up Throughout Old Age
Diagnosis and treatment of high-grade cervical dysplasia substantially increases the risk of cervical or vaginal cancer at or after age 60 years, a study finds.
Cervical Cancer: Is a New Detection Method Coming?
A simple blood test using plasma thermogram could serve as an effective new indicator for detecting cervical cancer, including assessment of the cancer’s stage.
Cervical Cancer: Newly Discovered Gene Mutations May Lead to More Targeted Therapies
Researchers discovered 13 gene mutations of significance in cervical cancer, including 8 mutations not previously linked to cervical cancer and 2 mutations novel to any type of cancer.
Female Providers, Residents More Likely to Order HPV Testing for Low-Risk Women
Female providers were twice as likely as their male counterparts to order HPV testing for low-risk women aged 30 to 65 who had normal Pap smear results.
Can Retinoids Prevent CIN Progression?
Retinoids may have some effect on regression of certain grades of cervical intraepithelial neoplasia (CIN) but do not prevent disease progression.